Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhongsheng Suyuan Biotechnology Co., Ltd. is a specialized high-tech enterprise focused on the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and clinical laboratory instruments. As a subsidiary of China National Biotec Group (CNBG) under the Sinopharm umbrella, the company plays a significant role in China's domestic diagnostic market. Its extensive product portfolio includes diagnostic kits for clinical chemistry, immunodiagnostics, and specific protein analysis, covering critical areas such as liver and kidney function, lipid metabolism, and cardiac markers. Zhongsheng Suyuan operates advanced production facilities that adhere to international quality standards, including ISO 9001 and ISO 13485 certifications. The company is dedicated to providing reliable and efficient diagnostic solutions to hospitals, clinics, and research institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongsheng Suyuan.